Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
February 24th, 2023
Cogstate Acquisition Discussions Halted
Read More
February 24th, 2023
Anteris Technologies Raises $35 Million
Read More
February 3rd, 2023
Aroa Biosurgery on Track with Sales and Move to Profitability
Read More
February 3rd, 2023
Bio-Gene Strikes Significant Deal with STK Bio-Ag Technologies
Read More
December 23rd, 2022
Top 6 Stock Picks for 2023
Read More
December 23rd, 2022
2023 Top Six Pick - Aroa Biosurgery: A Defensive Growth Stock for Investors
Read More
December 19th, 2022
Adalta Returns to IV Formulation for AD-214
Read More
December 19th, 2022
Dimerix Completes Recruitment of First Stage in Phase III Study
Read More
December 19th, 2022
Lecanemab Data Presented; Positive News for Cogstate
Read More
December 18th, 2022
Anteris Technologies to Progress Heart Valve to Early Feasibility Study
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
